Welcome to our dedicated page for P3 HEALTH PARTNERS news (Ticker: PIII), a resource for investors and traders seeking the latest updates and insights on P3 HEALTH PARTNERS stock.
P3 Health Partners Inc. reports developments in population health management, value-based primary care and physician-led care coordination. The company supports community providers through administrative services, clinical operations, data-driven care enablement and partnerships tied to Medicare Advantage, accountable care organizations and delegated-risk arrangements.
Recurring updates include quarterly results, guidance, revenue trends, capitated revenue per member, medical margin, adjusted EBITDA and operating changes in the Care Enablement Model. Company news also covers payer and provider agreements, ACO management services, market expansion, investor conference participation and joint venture activity such as the P3 Commonwealth Innovation MSO.
Summary not available.
P3 Health Partners Oregon has announced a multi-year partnership with Oregon State University Athletics, enhancing its visibility among senior fans. Starting in the 2022-23 season, P3 will introduce the first-ever Oregon State University Senior Cheer Squad. This initiative will include performances during women’s basketball games and coverage in digital programs. P3 will also sponsor game broadcasts, starting lineups for home basketball matches, and special events like Grandparents Day. This collaboration aims to strengthen community ties and engage senior patients who have connections with the university.
P3 Health Partners (NASDAQ: PIII) has been added to the Russell 3000 Index, effective June 27, 2022, marking a significant milestone for the company. This inclusion enhances visibility and liquidity for shareholders and confirms the company’s position among the top 4,000 U.S. stocks based on market capitalization. FTSE Russell, which manages the Russell indexes, oversees approximately $12 trillion in assets benchmarked against these indexes, further solidifying P3's market presence as it continues to work towards its strategic vision of transforming healthcare.
Summary not available.
P3 Health Partners, Inc. (NASDAQ: PIII) will release its financial results for Q4 and full year 2021 on April 25, 2022, after market close. A conference call and webcast for investors will be held the same day at 4:30 PM ET. The company anticipates reporting revenue and adjusted EBITDA aligning with preliminary results shared on March 9, 2022. P3 has filed for a 15-day extension for its Form 10-K due to incomplete disclosures, but reports no disagreements with its auditors.
P3 Health Partners reported a strong revenue growth of 46% for Q4 2021 and 32% for the full year, projecting 2022 revenue up to $1 billion (a 56% increase). The company aims for 95,000 at-risk Medicare Advantage members by year-end, a 42% rise. Adjusted EBITDA is expected to improve significantly, with profitability anticipated by 2024. Despite a net loss of up to $95 million for Q4, a robust cash position of $140 million at year-end supports operations. P3 will file for a late 10-K extension, expecting to release detailed results by April 15, 2022.
P3 Health Partners, Inc. (NASDAQ: PIII), a physician-led population health management company, announced its participation in three investor conferences in March 2022. The company will present at the Cowen 42nd Annual Healthcare Conference on March 9, attend the 34th Annual ROTH Conference on March 14 in Dana Point, CA, and participate in the Barclays Global Healthcare Conference on March 16 in Miami, FL. Live webcasts will be available on P3’s investor relations website, providing access to presentations and replays.
P3 Health Partners has successfully acquired Medcore HP and Omni IPA Medical Group, adding over 10,500 Medicare Advantage members in California. This acquisition marks P3's entry into its fifth state, enhancing its national expansion strategy.
Medcore HP is licensed under California's Knox-Keene Act, allowing it to manage global risk for its members, while Omni IPA comprises over 400 healthcare providers. CEO Sherif Abdou emphasized that this move aligns with P3's mission to improve healthcare outcomes through value-based care.
P3 Health Partners (NASDAQ: PIII) has announced its participation in the 40th Annual J.P. Morgan Healthcare Conference, scheduled for January 12, 2022. CEO Dr. Sherif Abdou and the management team will present virtually at 5:15 p.m. ET. Interested parties can access the live webcast on P3's investor website, with a replay available afterwards. P3 focuses on patient-centered, physician-led population health management, aiming to enhance patient outcomes while reducing care costs through integrated care models and technology.
P3 Health Partners has completed its business combination with Foresight Acquisition Corp., with trading commencing on December 6, 2021, under the ticker symbols PIII and PIIIW on Nasdaq. The merger positions P3 as a public company aiming to improve population health management through its value-based care model, which focuses on empowering patients and providers. P3's management team, led by physician-experts, is committed to expanding operations and addressing significant healthcare challenges, including rising costs and access issues.